A5031283871- Glioma Diagnosis and Treatment
- Brain Metastases and Treatment
- Meningioma and schwannoma management
- Cancer Treatment and Pharmacology
- CNS Lymphoma Diagnosis and Treatment
- Cancer survivorship and care
- Palliative Care and End-of-Life Issues
- Pituitary Gland Disorders and Treatments
- Pharmacological Effects and Toxicity Studies
- Soft tissue tumor case studies
- Infectious Diseases and Tuberculosis
- Cerebrospinal fluid and hydrocephalus
- Amyotrophic Lateral Sclerosis Research
- Neuroblastoma Research and Treatments
- Cancer-related cognitive impairment studies
- Bipolar Disorder and Treatment
- Patient-Provider Communication in Healthcare
- Electroconvulsive Therapy Studies
- Childhood Cancer Survivors' Quality of Life
- Genetic Neurodegenerative Diseases
- Venous Thromboembolism Diagnosis and Management
- Family Support in Illness
- Management of metastatic bone disease
- Lymphoma Diagnosis and Treatment
- Histone Deacetylase Inhibitors Research
Fondazione IRCCS Istituto Neurologico Carlo Besta
2014-2024
Mylan (South Africa)
2024
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2001-2018
University of Milan
2001-2018
Istituti di Ricovero e Cura a Carattere Scientifico
2001-2018
International Neuromodulation Society
2013
Mario Negri Institute for Pharmacological Research
2003-2013
IRCCS Istituto Auxologico Italiano
2003
Ospedale Maggiore
2001
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
1995
Lombardy was severely hit by the COVID-19 pandemic since February 2020 and Health System underwent rapid reorganization. Outpatient clinics were stopped for non-urgent patients: it became a priority to manage hundreds of fragile neurological patients who suddenly had less reference points. In Italy, before pandemic, Televisits neither recognized nor priced. At Fondazione IRCCS Istituto Neurologico C. Besta, we reorganized outpatient deliver Neuro-telemedicine services, including...
Bipolar disorder (BD) is a severe mental with wide range of cognitive deficits, both in the euthymic and acute phase disease. Interestingly, recent years, there has been growing interest investigating impact ω-3 polyunsaturated fatty acids on cognition BD. In this context, aim study to evaluate effect docosahexaenoic acid (C22:6 ω-3, DHA) supplementation performances BD patients. This an exploratory, single-centre, double-blind randomized controlled trial evaluating 12 weeks DHA (1250 mg...
Quality of life (QoL) is an increasingly important outcome measure in medicine.Health, fact, not only based on functional status but also psychological and social well being.Since QoL related to the patient's perception their position relation goals, expectations, standards concerns, way which medical context experienced may be critical.We then hypothesised that self-perceived linked unmet needs information management decision involvement.To analyse this hypothesis, we conducted a...